Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry.

Alonso-Dominguez JM, Castaño-Bonilla T, Gil C, Serrano-Lopez J, Martinez-Sanchez P, Herrera P, Garcia-Boyero R, Rodriguez-Arboli E, Brioso-Infante J, Benavente C, Lavilla-Rubira E, Tormo M, Sayas-Lloris MJ, Lainez-Gonzalez D, Serrano-Lopez J, Amigo ML, Algarra L, Unamunzaga A, Alonso-Alonso JM, Garcia-Garay MC, Callejas-Charavia M, Roldan-Perez A, Cornago-Navascues J, Valero-Nuñez M, Alfonso-Pierola A, Perez-Santaolalla E, Sobas M, Romero-Riquelme M, Lopez M, Galvez K, Rodríguez-Veiga R, Barragan E, Ayala R, Solana-Altabella A, Lloret-Madrid P, Montesinos P

Open source

DOI
10.1002/cncr.70353
Published
2026 Apr 15
Container
Cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cncr.70353,
  title = {Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry.},
  author = {Alonso-Dominguez JM and Castaño-Bonilla T and Gil C and Serrano-Lopez J and Martinez-Sanchez P and Herrera P and Garcia-Boyero R and Rodriguez-Arboli E and Brioso-Infante J and Benavente C and Lavilla-Rubira E and Tormo M and Sayas-Lloris MJ and Lainez-Gonzalez D and Serrano-Lopez J and Amigo ML and Algarra L and Unamunzaga A and Alonso-Alonso JM and Garcia-Garay MC and Callejas-Charavia M and Roldan-Perez A and Cornago-Navascues J and Valero-Nuñez M and Alfonso-Pierola A and Perez-Santaolalla E and Sobas M and Romero-Riquelme M and Lopez M and Galvez K and Rodríguez-Veiga R and Barragan E and Ayala R and Solana-Altabella A and Lloret-Madrid P and Montesinos P},
  year = {2026},
  journal = {Cancer},
  doi = {10.1002/cncr.70353},
  url = {https://doi.org/10.1002/cncr.70353}
}

RIS

TY  - JOUR
TI  - Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry.
AU  - Alonso-Dominguez JM
AU  - Castaño-Bonilla T
AU  - Gil C
AU  - Serrano-Lopez J
AU  - Martinez-Sanchez P
AU  - Herrera P
AU  - Garcia-Boyero R
AU  - Rodriguez-Arboli E
AU  - Brioso-Infante J
AU  - Benavente C
AU  - Lavilla-Rubira E
AU  - Tormo M
AU  - Sayas-Lloris MJ
AU  - Lainez-Gonzalez D
AU  - Serrano-Lopez J
AU  - Amigo ML
AU  - Algarra L
AU  - Unamunzaga A
AU  - Alonso-Alonso JM
AU  - Garcia-Garay MC
AU  - Callejas-Charavia M
AU  - Roldan-Perez A
AU  - Cornago-Navascues J
AU  - Valero-Nuñez M
AU  - Alfonso-Pierola A
AU  - Perez-Santaolalla E
AU  - Sobas M
AU  - Romero-Riquelme M
AU  - Lopez M
AU  - Galvez K
AU  - Rodríguez-Veiga R
AU  - Barragan E
AU  - Ayala R
AU  - Solana-Altabella A
AU  - Lloret-Madrid P
AU  - Montesinos P
PY  - 2026
JO  - Cancer
DO  - 10.1002/cncr.70353
UR  - https://doi.org/10.1002/cncr.70353
ER  - 

APA

JM, A., T, C., C, G., J, S., P, M., P, H., R, G., E, R., J, B., C, B., E, L., M, T., MJ, S., D, L., J, S., ML, A., L, A., A, U., JM, A., MC, G., M, C., A, R., J, C., M, V., A, A., E, P., M, S., M, R., M, L., K, G., R, R., E, B., R, A., A, S., P, L., & P, M. (2026). Reassessing adverse prognosis of acute myeloid leukemia harboring BCR::ABL1 in the era of tyrosine kinase inhibitors: A real-world analysis from the PETHEMA registry.. Cancer. https://doi.org/10.1002/cncr.70353

Source records